Published in Medicine and Law Weekly, June 30th, 2006
The purpose of the new agreement is to protect the company and its shareholders from unsolicited attempts or inequitable offers to acquire the company. The rights agreement has no immediate dilutive effect and does not diminish the ability of Synovis or its shareholders to accept a fair offer to acquire the company in a negotiated transaction.
To implement this shareholder rights agreement, the company has declared a distribution of one common share purchase right on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.